Growing evidence has shown that NNMT is aberrantly expressed in several cancers and is a promising prognostic predictor in cancers such as gastric carcinoma, oral squamous cell carcinoma, ovarian cancer, hepatocellular carcinoma, and nasopharyngeal carcinoma [19–23]. This evidence concerns the gene NNMT and hepatocellular carcinoma.